Adial Pharmaceuticals News

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Futu NewsNov 16, 2024 05:32

Adial Pharmaceuticals Analyst Ratings

BenzingaNov 14, 2024 19:53

Rodman & Renshaw Initiates Coverage On Adial Pharmaceuticals With Buy Rating, Announces Price Target of $8

BenzingaNov 14, 2024 19:53

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Futu NewsSep 21, 2024 00:32

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Futu NewsAug 16, 2024 02:32

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Futu NewsJul 25, 2024 20:54

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Futu NewsJul 25, 2024 04:52

Analysts Conflicted on These Healthcare Names: ADC Therapeutics (ADCT), Adial Pharmaceuticals (ADIL) and Steris (STE)

TipRanksApr 11, 2024 23:35

Watching Adial Pharmaceuticals; Brookline Capital Markets Says 'We Believe The Announcement Of A New Patent Issuance Increases The Potential For Partners To Engage With The Company' Reiterates Buy And $26 Price Target"

BenzingaFeb 15, 2024 02:21

Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target

BenzingaJul 12, 2023 17:59